NASDAQ:BWAY Brainsway Q3 2026 Earnings Date & Estimates $11.57 +0.06 (+0.52%) As of 10:56 AM Eastern This is a fair market value price provided by Massive. Learn more. Brainsway is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, before market opens. The conference call is scheduled for 8:30 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 10, 2026TimeBefore Market OpensConference Call8:30 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Brainsway in Q3 2026Brainsway is expected to post earnings of $0.12 per share on revenue of $17.80 million. In the same quarter a year earlier Brainsway reported $0.04 per share on revenue of $13.51 million. Brainsway last reported on August 12, 2026, posting $0.14 per share and beating the $0.10 consensus estimate. Brainsway has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.12Expected Revenue$17.80 millionPrior-Year EPS$0.04Prior-Year Revenue$13.51 millionExpected EPS Growth+200.0%Expected Revenue Growth+31.7%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.14 (Beat by +$0.04)Last Quarter Revenue$17.11 millionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Brainsway Q3 2026 Earnings FAQ When does Brainsway report Q3 2026 earnings? Brainsway (NASDAQ:BWAY) is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Brainsway's Q3 2026 earnings call? Brainsway's Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Brainsway? Analysts expect Brainsway to post earnings of $0.12 per share for Q3 2026. How much revenue is Brainsway expected to report? The consensus revenue estimate for Brainsway is $17.80 million for Q3 2026. Brainsway Earnings HeadlinesBrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered LivesOctober 13 at 7:30 AM | globenewswire.comCritical Contrast: CONMED (NYSE:CNMD) and Brainsway (NASDAQ:BWAY)October 4, 2026 | americanbankingnews.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.October 15 at 1:00 AM | Altimetry (Ad)BrainsWay Announces Strong Pilot Results for Deep TMS in Depression with Early-Stage Alzheimer’sSeptember 30, 2026 | theglobeandmail.comBrainsWay: Execution Isn't The Problem, Market Size IsSeptember 22, 2026 | seekingalpha.comBrainsWay Ltd.(NasdaqGM:BWAY) dropped from S&P Global BMI IndexSeptember 21, 2026 | marketscreener.comMSee More Brainsway Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Brainsway? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Brainsway and other key companies, straight to your email. Email Address About BrainswayBrainsway (NASDAQ:BWAY) Ltd. is a medical technology company that develops and commercializes noninvasive treatments for brain disorders. Its primary technology, Deep Transcranial Magnetic Stimulation (Deep TMS), uses electromagnetic fields to stimulate targeted areas of the brain and is delivered through specialized treatment systems and helmet-like coils. The company’s Deep TMS platform is used by healthcare providers in the treatment of major depressive disorder, obsessive-compulsive disorder and smoking addiction, subject to applicable regulatory clearances and local treatment guidelines. BrainsWay also develops additional clinical applications for its technology, including potential treatments for other psychiatric and neurological conditions. Founded in 2003, BrainsWay serves hospitals, clinics and other healthcare providers in the United States and international markets. The company is headquartered in Burlington, Massachusetts, and has roots in Israel, where its technology was developed. Its shares trade on the Nasdaq under the symbol BWAY.View Brainsway ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Citi Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenBig Banks Report Strong Earnings—So Why Are Shares Falling?UnitedHealth Beats on Earnings, But Investors Question Growth PathIREN Limited's AI Pivot Gains Traction—But Can Its Data Centers Deliver?PBF Energy's Stunning Rally Faces a Critical TestA Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be? Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
